banner

Reverse Transcriptase

Cat. No. Product Name Inquiry
X24-06-ZQ883 Reverse transcriptase inhibitor Adefovir dipivoxil, Purity ≥98%
X24-06-ZQ896 Reverse transcriptase inhibitor Emtricitabine, Purity ≥98%
X24-06-ZQ899 Reverse transcriptase inhibitor Lamivudine, Purity ≥98%
X24-06-ZQ902 Reverse transcriptase inhibitor Nevirapine, Purity ≥98%
X24-06-ZQ908 Reverse transcriptase inhibitor Tenofovir disoproxil fumarate, Purity ≥98%
X24-06-ZQ918 Reverse transcriptase inhibitor Entecavir hydrate, Purity ≥98%
X24-06-ZQ928 Reverse transcriptase inhibitor Etravirine, Purity ≥98%
X24-06-ZQ941 Reverse transcriptase inhibitor Rilpivirine, Purity ≥98%
X24-06-ZQ956 Reverse transcriptase inhibitor MIV-150, Purity ≥98%
X24-06-ZQ961 Reverse transcriptase inhibitor Doravirine, Purity ≥98%
X24-06-ZQ966 Reverse transcriptase inhibitor Dapivirine, Purity ≥98%
X24-06-ZQ967 Reverse transcriptase inhibitor UK-453061, Purity ≥98%
X24-06-ZQ997 Reverse transcriptase inhibitor Elvucitabine, Purity ≥98%
X24-07-ZQ019 Reverse transcriptase inhibitor GS-7340, Purity ≥98%
X24-07-ZQ117 Reverse transcriptase inhibitor Tenofovir disoproxil, Purity ≥98%
X24-07-ZQ118 Reverse transcriptase inhibitor Tenofovir hydrate, Purity ≥98%
X24-07-ZQ119 Reverse transcriptase inhibitor Tenofovir alafenamide fumarate, Purity ≥98%
X24-07-ZQ120 Reverse transcriptase inhibitor Tenofovir alafenamide hemifumarate, Purity ≥98%
X24-07-ZQ124 Reverse transcriptase inhibitor 4'-Ethynyl-2'-deoxyadenosine, Purity ≥98%
X24-07-ZQ139 Reverse transcriptase inhibitor Emtricitabine S-oxide, Purity ≥98%

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

  • SUITE 201, 17 Ramsey Road, Shirley, NY 11967, USA
  • 1-631-637-6119
Copyright © 2025 CD BioGlyco. All rights reserved.
0
There is no product in your cart.

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x